公开(公告)号：US12077571B2

公开(公告)日：2024-09-03

申请号：US18186064

申请日：2023-03-17

Applicant: Novartis AG

Inventor： Johanna Abend ,  Zorica Dragic ,  Adam Lloyd Feire ,  Mark Knapp ,  Steven Kovacs ,  Elisabetta Traggiai ,  Lichun Wang ,  Yongqiang Wang ,  Danqing Wu ,  Qilong Wu ,  Fangmin Xu

IPC: A61K45/06 ,  A61K9/19 ,  A61K39/42 ,  C07K16/08

CPC classification number: C07K16/084 ,  A61K9/19 ,  A61K39/42 ,  A61K45/06 ,  C07K2317/20 ,  C07K2317/21 ,  C07K2317/24 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/41 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/622 ,  C07K2317/76 ,  C07K2317/92

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

公开(公告)号：US10435460B2

公开(公告)日：2019-10-08

申请号：US15829115

申请日：2017-12-01

Applicant: Novartis AG

Inventor： Johanna Abend ,  Zorica Dragic ,  Adam Lloyd Feire ,  Mark Knapp ,  Steven Kovacs ,  Elisabetta Traggiai ,  Lichun Wang ,  Yongqiang Wang ,  Danqing Wu ,  Qilong Wu ,  Fangmin Xu

IPC: A61K39/12 ,  A61K39/42 ,  C07K16/08 ,  A61K45/06 ,  A61K9/19

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

公开(公告)号：US11639378B2

公开(公告)日：2023-05-02

申请号：US17502910

申请日：2021-10-15

Applicant: Novartis AG

Inventor： Johanna Abend ,  Zorica Dragic ,  Adam Lloyd Feire ,  Mark Knapp ,  Steven Kovacs ,  Elisabetta Traggiai ,  Lichun Wang ,  Yongqiang Wang ,  Danqing Wu ,  Qilong Wu ,  Fangmin Xu

IPC: A61K39/395 ,  C07K16/08 ,  A61K39/42 ,  A61K45/06 ,  A61K9/19

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

公开(公告)号：US11161894B2

公开(公告)日：2021-11-02

申请号：US16657855

申请日：2019-10-18

Applicant: Novartis AG

Inventor： Johanna Abend ,  Zorica Dragic ,  Adam Lloyd Feire ,  Mark Knapp ,  Steven Kovacs ,  Elisabetta Traggiai ,  Lichun Wang ,  Yongqiang Wang ,  Danqing Wu ,  Qilong Wu ,  Fangmin Xu

IPC: A61K39/42 ,  A61K45/06 ,  A61K9/19 ,  C07K16/08

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

公开(公告)号：US10654914B2

公开(公告)日：2020-05-19

申请号：US16183262

申请日：2018-11-07

Applicant: Novartis AG

Inventor： Johanna Abend ,  Zorica Dragic ,  Adam Lloyd Feire ,  Mark Knapp ,  Steven Kovacs ,  Elisabetta Traggiai ,  Lichun Wang ,  Yongqiang Wang ,  Danqing Wu ,  Qilong Wu ,  Fangmin Xu

IPC: A61K9/19 ,  A61K39/42 ,  C07K16/08 ,  A61K45/06

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

公开(公告)号：US10450366B2

公开(公告)日：2019-10-22

申请号：US15758491

申请日：2016-09-08

Applicant: Novartis AG

Inventor： Johanna Abend ,  Zorica Dragic ,  Adam Lloyd Feire ,  Mark Knapp ,  Steven Kovacs ,  Elisabetta Traggiai ,  Lichun Wang ,  Yongqiang Wang ,  Danqing Wu ,  Qilong Wu ,  Fangmin Xu

IPC: A61K39/00 ,  A61K39/42 ,  C07K16/00 ,  C07K16/08 ,  A61K45/06 ,  A61K9/19

Abstract: The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.